Our main interest is the characterization of compounds to support the development of
alternatives to currently marketed drugs that are losing effectiveness due to the development of …

SARS-CoV-2, the etiological agent of COVID-19, was first described in Wuhan, China in
December 2019 and has now spread globally. Ecuador was the second country in South …

Although COVID-19 (coronavirus disease of 2019) has been primarily contained in humans
through widespread vaccination, the impact and incidence of SARS-CoV-2 (Severe acute …

SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an
individual who has already recovered from a previous episode of COVID-19. The first case of …

The Omicron variant of SARS-CoV-2 is the latest pandemic lineage causing COVID-19.
Despite having a vaccination rate ≥85%, Ecuador recorded a high incidence of Omicron from …

Background SARS-CoV-2 uses the human cell receptor angiotensin-converting enzyme (ACE2).
ACE2 is widely present in the cardiovascular system including the myocardium and the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that,
since March 2020, has been responsible for a global and ongoing pandemic. Its rapid spread …

In this paper, we present a new content-based readability indexing method using the
dimensionality reduction algorithm called Concept Indexing (CI). Corpus-based simulations were …

Recent studies cast doubt on the ability of abstract experiments to predict decision‐making
in the field. Thus, scholars have argued for more ‘realism’ by introducing context to field …

Background The rapid spread of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC)
is an urgent global health threat. We examined child caretaker knowledge, attitudes, …